NasdaqCM - Nasdaq Real Time Price
USD
Xilio Therapeutics, Inc. (XLO)
7.05
-0.88
(-11.10%)
As of 9:57:59 AM EDT. Market Open.
Loading chart for XLO
- Previous Close
7.93 - Open
7.05 - Bid 7.55 x 100
- Ask 8.46 x 400
- Day's Range
7.05 - 7.05 - 52 Week Range
6.47 - 12.32 - Volume
591 - Avg. Volume
12,462 - Market Cap (intraday)
46.391M - Beta (5Y Monthly) -0.12
- PE Ratio (TTM)
-- - EPS (TTM)
-0.60 - Earnings Date (est.) --
- Forward Dividend & Yield -- (0.00%)
- 1y Target Est
18.00 - Zacks Rating Neutral
Recent News
View MorePerformance Overview
Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
XLO
21.32%
S&P 500 (^GSPC)
11.30%
1-Year Return
XLO
37.37%
S&P 500 (^GSPC)
11.68%
3-Year Return
XLO
76.02%
S&P 500 (^GSPC)
82.85%
5-Year Return
XLO
97.00%
S&P 500 (^GSPC)
65.44%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
-34.06%
-
Return on Assets (ttm)
-13.61%
-
Return on Equity (ttm)
-55.03%
-
Revenue (ttm)
64.09M
-
Net Income Avi to Common (ttm)
-21.83M
-
Diluted EPS (ttm)
-0.60
Balance Sheet and Cash Flow
-
Total Cash (mrq)
136.04M
-
Total Debt/Equity (mrq)
8.72%
-
Levered Free Cash Flow (ttm)
-37.56M
